BioConvergence LLC, a life sciences contract service provider, has recently acquired two Ultra High Performance Liquid Chromatography (UHPLC) systems.


Bloomington, IN (February 2, 2016)–The development laboratory at BioConvergence has recently acquired two 2015 Vanquish™ UHPLC Systems; each equipped with a Vanquish Diode Array Detector HL (DAD) with Thermo Scientific™ LightPipe™ technology. The Vanquish UHPLC systems have the ability to perform at pressures up to 22,000 psi, allow the use of smaller sample sizes, and use less reagents. The DAD achieves excellent signal-to-noise performance through minimal baseline noise, a long detection light source, and low peak dispersion. Improved detection through the DAD provides better peak separation to provide earlier detection if samples begin to degrade or change as a result of storage conditions. These factors all combine for more repeatable results and better chromatography.

BioConvergence invested in the additional UHPLC systems in order to increase capacity, as well as to improve analysis. Ken Chomistek, the Product and Analytical Development Manager at BioConvergence, further explained, “The UHPLC systems allow us to use smaller quantities of clients’ valuable materials while performing all types of studies. Also, this addition to our laboratory will make methods transfers easier, allowing us to improve service to our clients.”

For more information on analytical testing or other laboratory services at BioConvergence, visit or contact BioConvergence at

About BioConvergence
BioConvergence is a contract service provider to the life sciences industry, offering outsourcing partnerships for formulation development, testing, labeling and kitting, and supply chain services. Headquartered in Bloomington, Indiana, BioConvergence has over 50 employees with many years of valuable experience in the pharmaceutical and biotechnology industries. The unique E-Transparency® System provides transparency and flexibility to clients, while offering superior, quality-driven outsourcing services. For more information, visit

BioConvergence® Expands GMP Analytical Testing Capabilities with Two New UHPLCs